Competitive Grants Program
Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts Details-
Title Grant Type Focus Area Country Application Due Date Real World Evidence on the Impact of Early and Appropriate Use of Aztreonam-Avibactam (ATM-AVI)Release Date:Research Inflammation & Immunology Brazil, Chile, India, Italy, South Africa, Spain, United Kingdom Guideline Concordant Care and New Data for Patients with MIBC through la/mUCEducation Oncology USA Clinical Research Studies of Atirmociclib in HR+/HER2- and/or HER2+ Breast CancerRelease Date:Research Oncology Australia, Brazil, Canada, China, France, Germany, Italy, Japan, Korea, Mexico, Spain, Taiwan, USA, United Kingdom Quality Improvement Interventions to Enhance the Care of Patients Infected by MBL-CRE or S. maltophiliaRelease Date:Quality Improvement Inflammation & Immunology Australia, Chile, India, Italy, Spain, United Kingdom Advancing Real-World Evidence in Idiopathic Inflammatory Myopathies Through a German Disease RegistryRelease Date:Research Inflammation & Immunology Germany Real-World Evidence on Clinical Outcomes with ATM-AVI in Adult Patients with Stenotrophomonas maltophilia InfectionsRelease Date:Research Inflammation & Immunology China Real-World Evidence on Clinical Outcomes with Aztreonam-Avibactam (ATM-AVI) in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Tissue Penetration and Correlation with Clinical Outcomes of ATM-AVI in Adult Patients with Limited Treatment OptionsRelease Date:Research Inflammation & Immunology China Advancing Multidisciplinary Care in HemophiliaRelease Date:Quality Improvement Rare Disease China BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple MyelomaRelease Date:Education Oncology USA -
Title Grant Type Focus Area Country Application Due Date Updates in RSV Prevention for Prenatal Care Workers Serving Marginalized CommunitiesRelease Date:Education Vaccines USA Acquired Aplastic Anemia: Educational programs to upskill hematologists & primary care physicians with current best practicesRelease Date:Education Hospital All Bridging the Inflammatory Dermatosis Care Divide with TeledermatologyRelease Date:Partner: The George Washington UniversityQuality Improvement Inflammation & Immunology USA Knowledge Gaps in Drug-Drug Interactions in COVID-19 Outpatient TreatmentRelease Date:Education Vaccines USA Optimizing COVID-19 Treatment Strategies in Elderly Vulnerable Populations in CanadaRelease Date:Quality Improvement Vaccines Canada Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Research in CanadaRelease Date:Research Rare Disease Canada Improving access to and the quality of clinical diagnostic solutions (Africa Geographic Scope)Release Date:Quality Improvement Support for the Professions All Patient Education and Support for the Management of MigraineRelease Date:Education Internal Medicine All Advancing Management and Care in Atrial Fibrillation and Venous Thromboembolism (ex-US)Education Internal Medicine All Raising Awareness and Promoting Timely Diagnosis of TTR AmyloidosisRelease Date:Partner: Global Bridges at Mayo ClinicQuality Improvement Rare Disease All Accord for a Healthier World: Antimicrobial Resistance Testing & Stewardship to Improve Hospitalized Patients’ Health OutcomesRelease Date:Quality Improvement Hospital Malawi, Rwanda, Senegal Updates in Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing ResearchRelease Date:Education Vaccines USA